Thongon, N., Castiglioni, I., Zucal, C., Latorre, E., D'Agostino, V., Bauer, I., . . . Provenzani, A. (2016). The GSK3β inhibitor BIS I reverts YAP-dependent EMT signature in PDAC cell lines by decreasing SMADs expression level. Oncotarget.
Chicago-stil citatThongon, Natthakan, et al. "The GSK3β Inhibitor BIS I Reverts YAP-dependent EMT Signature in PDAC Cell Lines By Decreasing SMADs Expression Level." Oncotarget 2016.
MLA-referensThongon, Natthakan, et al. "The GSK3β Inhibitor BIS I Reverts YAP-dependent EMT Signature in PDAC Cell Lines By Decreasing SMADs Expression Level." Oncotarget 2016.
Varning: dessa hänvisningar är inte alltid fullständigt riktiga.